#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1. Introduction
1-1	0-2	1.	_	_	_	_
1-2	3-15	Introduction	abstract	new	_	_

#Text=Lipid oxidation is one of the major causes of food deterioration , leading to the loss of nutrients and bioactives , off flavors development , and could also form potentially toxic compounds .
2-1	16-21	Lipid	person|abstract[3]	new|new[3]	coref|coref	3-20|3-20[19_3]
2-2	22-31	oxidation	abstract[3]	new[3]	_	_
2-3	32-34	is	_	_	_	_
2-4	35-38	one	abstract[4]	new[4]	_	_
2-5	39-41	of	abstract[4]	new[4]	_	_
2-6	42-45	the	abstract[4]|abstract[5]	new[4]|new[5]	_	_
2-7	46-51	major	abstract[4]|abstract[5]	new[4]|new[5]	_	_
2-8	52-58	causes	abstract[4]|abstract[5]	new[4]|new[5]	_	_
2-9	59-61	of	abstract[4]|abstract[5]	new[4]|new[5]	_	_
2-10	62-66	food	abstract[4]|abstract[5]|substance|abstract[7]	new[4]|new[5]|new|new[7]	coref	9-20
2-11	67-80	deterioration	abstract[4]|abstract[5]|abstract[7]	new[4]|new[5]|new[7]	_	_
2-12	81-82	,	_	_	_	_
2-13	83-90	leading	_	_	_	_
2-14	91-93	to	_	_	_	_
2-15	94-97	the	abstract[8]	new[8]	_	_
2-16	98-102	loss	abstract[8]	new[8]	_	_
2-17	103-105	of	abstract[8]	new[8]	_	_
2-18	106-115	nutrients	abstract[8]|substance	new[8]|new	_	_
2-19	116-119	and	abstract[8]	new[8]	_	_
2-20	120-130	bioactives	abstract[8]|substance[10]	new[8]|new[10]	_	_
2-21	131-132	,	abstract[8]|substance[10]	new[8]|new[10]	_	_
2-22	133-136	off	abstract[8]|substance[10]	new[8]|new[10]	_	_
2-23	137-144	flavors	abstract[8]|substance[10]|abstract|abstract[12]	new[8]|new[10]|new|new[12]	coref	7-23[56_0]
2-24	145-156	development	abstract[8]|substance[10]|abstract[12]	new[8]|new[10]|new[12]	_	_
2-25	157-158	,	_	_	_	_
2-26	159-162	and	_	_	_	_
2-27	163-168	could	_	_	_	_
2-28	169-173	also	_	_	_	_
2-29	174-178	form	abstract	new	coref|none	14-26[111_0]|2-29[0_111]
2-30	179-190	potentially	substance[13]	new[13]	coref	7-14[53_13]
2-31	191-196	toxic	substance[13]	new[13]	_	_
2-32	197-206	compounds	substance[13]	new[13]	_	_
2-33	207-208	.	_	_	_	_

#Text=The use of synthetic antioxidants , such as butylated hydroxytoluene , butylated hydroxyanisole , or n-propyl gallate to delay lipid oxidation is currently questioned due to their possible harmful effects on human health , and the use of natural antioxidants is of growing interest .
3-1	209-212	The	abstract[14]	new[14]	_	_
3-2	213-216	use	abstract[14]	new[14]	_	_
3-3	217-219	of	abstract[14]	new[14]	_	_
3-4	220-229	synthetic	abstract[14]|substance[15]	new[14]|new[15]	ana	3-27[0_15]
3-5	230-242	antioxidants	abstract[14]|substance[15]	new[14]|new[15]	_	_
3-6	243-244	,	abstract[14]|substance[15]	new[14]|new[15]	_	_
3-7	245-249	such	abstract[14]|substance[15]	new[14]|new[15]	_	_
3-8	250-252	as	abstract[14]|substance[15]	new[14]|new[15]	_	_
3-9	253-262	butylated	abstract[14]|substance[15]	new[14]|new[15]	_	_
3-10	263-277	hydroxytoluene	abstract[14]|substance[15]	new[14]|new[15]	_	_
3-11	278-279	,	abstract[14]|substance[15]	new[14]|new[15]	_	_
3-12	280-289	butylated	abstract[14]|substance[15]|substance[16]	new[14]|new[15]|new[16]	_	_
3-13	290-304	hydroxyanisole	abstract[14]|substance[15]|substance[16]	new[14]|new[15]|new[16]	_	_
3-14	305-306	,	abstract[14]|substance[15]	new[14]|new[15]	_	_
3-15	307-309	or	abstract[14]|substance[15]	new[14]|new[15]	_	_
3-16	310-318	n-propyl	abstract[14]|substance[15]|substance[17]	new[14]|new[15]|new[17]	_	_
3-17	319-326	gallate	abstract[14]|substance[15]|substance[17]	new[14]|new[15]|new[17]	_	_
3-18	327-329	to	_	_	_	_
3-19	330-335	delay	_	_	_	_
3-20	336-341	lipid	person|event[19]	giv|giv[19]	coref|coref	5-9|5-9[33_19]
3-21	342-351	oxidation	event[19]	giv[19]	_	_
3-22	352-354	is	_	_	_	_
3-23	355-364	currently	_	_	_	_
3-24	365-375	questioned	_	_	_	_
3-25	376-379	due	_	_	_	_
3-26	380-382	to	_	_	_	_
3-27	383-388	their	substance|abstract[21]	giv|new[21]	coref	3-39[24_0]
3-28	389-397	possible	abstract[21]	new[21]	_	_
3-29	398-405	harmful	abstract[21]	new[21]	_	_
3-30	406-413	effects	abstract[21]	new[21]	_	_
3-31	414-416	on	abstract[21]	new[21]	_	_
3-32	417-422	human	abstract[21]|abstract[22]	new[21]|new[22]	_	_
3-33	423-429	health	abstract[21]|abstract[22]	new[21]|new[22]	_	_
3-34	430-431	,	_	_	_	_
3-35	432-435	and	_	_	_	_
3-36	436-439	the	abstract[23]	new[23]	coref	3-43[25_23]
3-37	440-443	use	abstract[23]	new[23]	_	_
3-38	444-446	of	abstract[23]	new[23]	_	_
3-39	447-454	natural	abstract[23]|substance[24]	new[23]|giv[24]	_	_
3-40	455-467	antioxidants	abstract[23]|substance[24]	new[23]|giv[24]	_	_
3-41	468-470	is	_	_	_	_
3-42	471-473	of	_	_	_	_
3-43	474-481	growing	abstract[25]	giv[25]	_	_
3-44	482-490	interest	abstract[25]	giv[25]	_	_
3-45	491-492	.	_	_	_	_

#Text=In recent years , flavonoids have been used to improve the oxidative stability of foods .
4-1	493-495	In	_	_	_	_
4-2	496-502	recent	time[26]	new[26]	_	_
4-3	503-508	years	time[26]	new[26]	_	_
4-4	509-510	,	_	_	_	_
4-5	511-521	flavonoids	substance	new	coref	5-6
4-6	522-526	have	_	_	_	_
4-7	527-531	been	_	_	_	_
4-8	532-536	used	_	_	_	_
4-9	537-539	to	_	_	_	_
4-10	540-547	improve	_	_	_	_
4-11	548-551	the	abstract[28]	new[28]	coref	6-37[47_28]
4-12	552-561	oxidative	abstract[28]	new[28]	_	_
4-13	562-571	stability	abstract[28]	new[28]	_	_
4-14	572-574	of	abstract[28]	new[28]	_	_
4-15	575-580	foods	abstract[28]|substance	new[28]|new	_	_
4-16	581-582	.	_	_	_	_

#Text=The main mechanisms by which flavonoids act against lipid oxidation involve transferring a hydrogen atom or electrons to a peroxyl radical and metal chelation .
5-1	583-586	The	abstract[30]	new[30]	_	_
5-2	587-591	main	abstract[30]	new[30]	_	_
5-3	592-602	mechanisms	abstract[30]	new[30]	_	_
5-4	603-605	by	_	_	_	_
5-5	606-611	which	_	_	_	_
5-6	612-622	flavonoids	substance	giv	coref	6-1[39_0]
5-7	623-626	act	_	_	_	_
5-8	627-634	against	_	_	_	_
5-9	635-640	lipid	person|event[33]	giv|giv[33]	coref	6-27
5-10	641-650	oxidation	event[33]	giv[33]	_	_
5-11	651-658	involve	_	_	_	_
5-12	659-671	transferring	_	_	_	_
5-13	672-673	a	substance[34]	new[34]	_	_
5-14	674-682	hydrogen	substance[34]	new[34]	_	_
5-15	683-687	atom	substance[34]	new[34]	_	_
5-16	688-690	or	_	_	_	_
5-17	691-700	electrons	substance[35]	new[35]	_	_
5-18	701-703	to	substance[35]	new[35]	_	_
5-19	704-705	a	substance[35]|substance[38]	new[35]|new[38]	_	_
5-20	706-713	peroxyl	substance[35]|abstract|substance[38]	new[35]|new|new[38]	_	_
5-21	714-721	radical	substance[35]|substance[38]	new[35]|new[38]	_	_
5-22	722-725	and	substance[35]|substance[38]	new[35]|new[38]	_	_
5-23	726-731	metal	substance[35]|substance|substance[38]	new[35]|new|new[38]	_	_
5-24	732-741	chelation	substance[35]|substance[38]	new[35]|new[38]	_	_
5-25	742-743	.	_	_	_	_

#Text=Free flavonoids , mainly quercetin , myricetin , morin , ( +)catechin , ( −)epigallocatechin , ( −)epicatechin , and kaempferol have been incorporated in different lipid systems with varying degrees of success in terms of oxidative stability .
6-1	744-748	Free	substance[39]	giv[39]	appos	6-4[40_39]
6-2	749-759	flavonoids	substance[39]	giv[39]	_	_
6-3	760-761	,	_	_	_	_
6-4	762-768	mainly	substance[40]	giv[40]	coref	7-4[49_40]
6-5	769-778	quercetin	substance[40]	giv[40]	_	_
6-6	779-780	,	substance[40]	giv[40]	_	_
6-7	781-790	myricetin	substance[40]	giv[40]	_	_
6-8	791-792	,	substance[40]	giv[40]	_	_
6-9	793-798	morin	substance[40]	giv[40]	_	_
6-10	799-800	,	_	_	_	_
6-11	801-802	(	_	_	_	_
6-12	803-813	+)catechin	abstract	new	_	_
6-13	814-815	,	_	_	_	_
6-14	816-817	(	_	_	_	_
6-15	818-836	−)epigallocatechin	_	_	_	_
6-16	837-838	,	_	_	_	_
6-17	839-840	(	_	_	_	_
6-18	841-854	−)epicatechin	_	_	_	_
6-19	855-856	,	_	_	_	_
6-20	857-860	and	_	_	_	_
6-21	861-871	kaempferol	_	_	_	_
6-22	872-876	have	_	_	_	_
6-23	877-881	been	_	_	_	_
6-24	882-894	incorporated	_	_	_	_
6-25	895-897	in	_	_	_	_
6-26	898-907	different	object[43]	new[43]	coref	7-7[51_43]
6-27	908-913	lipid	organization|object[43]	giv|new[43]	coref	7-7
6-28	914-921	systems	object[43]	new[43]	_	_
6-29	922-926	with	object[43]	new[43]	_	_
6-30	927-934	varying	object[43]|abstract[44]	new[43]|new[44]	_	_
6-31	935-942	degrees	object[43]|abstract[44]	new[43]|new[44]	_	_
6-32	943-945	of	object[43]|abstract[44]	new[43]|new[44]	_	_
6-33	946-953	success	object[43]|abstract[44]|abstract	new[43]|new[44]|new	_	_
6-34	954-956	in	object[43]|abstract[44]	new[43]|new[44]	_	_
6-35	957-962	terms	object[43]|abstract[44]	new[43]|new[44]	_	_
6-36	963-965	of	object[43]|abstract[44]	new[43]|new[44]	_	_
6-37	966-975	oxidative	object[43]|abstract[44]|abstract|abstract[47]	new[43]|new[44]|new|giv[47]	coref	7-21[0_47]
6-38	976-985	stability	object[43]|abstract[44]|abstract[47]	new[43]|new[44]|giv[47]	_	_
6-39	986-987	.	_	_	_	_

#Text=The incorporation of free flavonoids in lipid systems may have some drawbacks since these phenolic compounds have limited solubility and stability , together with unpleasant flavors in some cases .
7-1	988-991	The	abstract[48]	new[48]	_	_
7-2	992-1005	incorporation	abstract[48]	new[48]	_	_
7-3	1006-1008	of	abstract[48]	new[48]	_	_
7-4	1009-1013	free	abstract[48]|substance[49]	new[48]|giv[49]	coref	8-3[0_49]
7-5	1014-1024	flavonoids	abstract[48]|substance[49]	new[48]|giv[49]	_	_
7-6	1025-1027	in	abstract[48]|substance[49]	new[48]|giv[49]	_	_
7-7	1028-1033	lipid	abstract[48]|substance[49]|organization|object[51]	new[48]|giv[49]|giv|giv[51]	coref|coref	12-22|12-22[97_51]
7-8	1034-1041	systems	abstract[48]|substance[49]|object[51]	new[48]|giv[49]|giv[51]	_	_
7-9	1042-1045	may	_	_	_	_
7-10	1046-1050	have	_	_	_	_
7-11	1051-1055	some	abstract[52]	new[52]	_	_
7-12	1056-1065	drawbacks	abstract[52]	new[52]	_	_
7-13	1066-1071	since	_	_	_	_
7-14	1072-1077	these	substance[53]	giv[53]	coref	9-16[67_53]
7-15	1078-1086	phenolic	substance[53]	giv[53]	_	_
7-16	1087-1096	compounds	substance[53]	giv[53]	_	_
7-17	1097-1101	have	_	_	_	_
7-18	1102-1109	limited	substance[54]	new[54]	_	_
7-19	1110-1120	solubility	substance[54]	new[54]	_	_
7-20	1121-1124	and	_	_	_	_
7-21	1125-1134	stability	abstract	giv	_	_
7-22	1135-1136	,	_	_	_	_
7-23	1137-1145	together	abstract[56]	giv[56]	_	_
7-24	1146-1150	with	abstract[56]	giv[56]	_	_
7-25	1151-1161	unpleasant	abstract[56]	giv[56]	_	_
7-26	1162-1169	flavors	abstract[56]	giv[56]	_	_
7-27	1170-1172	in	abstract[56]	giv[56]	_	_
7-28	1173-1177	some	abstract[56]|abstract[57]	giv[56]|new[57]	_	_
7-29	1178-1183	cases	abstract[56]|abstract[57]	giv[56]|new[57]	_	_
7-30	1184-1185	.	_	_	_	_

#Text=Encapsulation of flavonoids is a technology which could enhance the stability of flavonoids .
8-1	1186-1199	Encapsulation	abstract[58]	new[58]	coref	8-5[60_58]
8-2	1200-1202	of	abstract[58]	new[58]	_	_
8-3	1203-1213	flavonoids	abstract[58]|substance	new[58]|giv	coref	8-13
8-4	1214-1216	is	_	_	_	_
8-5	1217-1218	a	abstract[60]	giv[60]	coref	9-3[0_60]
8-6	1219-1229	technology	abstract[60]	giv[60]	_	_
8-7	1230-1235	which	_	_	_	_
8-8	1236-1241	could	_	_	_	_
8-9	1242-1249	enhance	_	_	_	_
8-10	1250-1253	the	abstract[61]	new[61]	_	_
8-11	1254-1263	stability	abstract[61]	new[61]	_	_
8-12	1264-1266	of	abstract[61]	new[61]	_	_
8-13	1267-1277	flavonoids	abstract[61]|substance	new[61]|giv	coref	12-15[94_0]
8-14	1278-1279	.	_	_	_	_

#Text=Among the encapsulation methods , spray-drying is the most widely used for the encapsulation of bioactive compounds in the food industry .
9-1	1280-1285	Among	_	_	_	_
9-2	1286-1289	the	abstract[64]	new[64]	_	_
9-3	1290-1303	encapsulation	abstract|abstract[64]	giv|new[64]	_	_
9-4	1304-1311	methods	abstract[64]	new[64]	_	_
9-5	1312-1313	,	_	_	_	_
9-6	1314-1326	spray-drying	substance	new	coref	15-7
9-7	1327-1329	is	_	_	_	_
9-8	1330-1333	the	_	_	_	_
9-9	1334-1338	most	_	_	_	_
9-10	1339-1345	widely	_	_	_	_
9-11	1346-1350	used	_	_	_	_
9-12	1351-1354	for	_	_	_	_
9-13	1355-1358	the	abstract[66]	new[66]	_	_
9-14	1359-1372	encapsulation	abstract[66]	new[66]	_	_
9-15	1373-1375	of	abstract[66]	new[66]	_	_
9-16	1376-1385	bioactive	abstract[66]|substance[67]	new[66]|giv[67]	_	_
9-17	1386-1395	compounds	abstract[66]|substance[67]	new[66]|giv[67]	_	_
9-18	1396-1398	in	abstract[66]|substance[67]	new[66]|giv[67]	_	_
9-19	1399-1402	the	abstract[66]|substance[67]|abstract[69]	new[66]|giv[67]|new[69]	_	_
9-20	1403-1407	food	abstract[66]|substance[67]|substance|abstract[69]	new[66]|giv[67]|giv|new[69]	_	_
9-21	1408-1416	industry	abstract[66]|substance[67]|abstract[69]	new[66]|giv[67]|new[69]	_	_
9-22	1417-1418	.	_	_	_	_

#Text=Inulin is a linear fructo-oligosaccharide composed of fructosyl units ( β ( 2→1 ) linkage ) and usually contains one terminal glucose moiety per molecule . β-linkage makes inulin resistant to hydrolysis by human gastrointestinal enzymes and it is classified as colonic delivery biopolymer .
10-1	1419-1425	Inulin	substance	new	coref	10-3[71_0]
10-2	1426-1428	is	_	_	_	_
10-3	1429-1430	a	substance[71]	giv[71]	coref	10-29[0_71]
10-4	1431-1437	linear	substance[71]	giv[71]	_	_
10-5	1438-1460	fructo-oligosaccharide	substance[71]	giv[71]	_	_
10-6	1461-1469	composed	_	_	_	_
10-7	1470-1472	of	_	_	_	_
10-8	1473-1482	fructosyl	organization[72]	new[72]	_	_
10-9	1483-1488	units	organization[72]	new[72]	_	_
10-10	1489-1490	(	_	_	_	_
10-11	1491-1492	β	quantity[73]	new[73]	_	_
10-12	1493-1494	(	quantity[73]	new[73]	_	_
10-13	1495-1498	2→1	quantity[73]	new[73]	_	_
10-14	1499-1500	)	quantity[73]	new[73]	_	_
10-15	1501-1508	linkage	object	new	_	_
10-16	1509-1510	)	_	_	_	_
10-17	1511-1514	and	_	_	_	_
10-18	1515-1522	usually	_	_	_	_
10-19	1523-1531	contains	_	_	_	_
10-20	1532-1535	one	substance[76]	new[76]	_	_
10-21	1536-1544	terminal	substance[76]	new[76]	_	_
10-22	1545-1552	glucose	substance|substance[76]	new|new[76]	_	_
10-23	1553-1559	moiety	substance[76]	new[76]	_	_
10-24	1560-1563	per	substance[76]	new[76]	_	_
10-25	1564-1572	molecule	substance[76]|abstract	new[76]|new	ana	10-38
10-26	1573-1574	.	_	_	_	_
10-27	1575-1584	β-linkage	substance	new	_	_
10-28	1585-1590	makes	_	_	_	_
10-29	1591-1597	inulin	substance	giv	coref	11-2
10-30	1598-1607	resistant	_	_	_	_
10-31	1608-1610	to	_	_	_	_
10-32	1611-1621	hydrolysis	substance[80]	new[80]	_	_
10-33	1622-1624	by	substance[80]	new[80]	_	_
10-34	1625-1630	human	substance[80]|object[81]	new[80]|new[81]	_	_
10-35	1631-1647	gastrointestinal	substance[80]|object[81]	new[80]|new[81]	_	_
10-36	1648-1655	enzymes	substance[80]|object[81]	new[80]|new[81]	_	_
10-37	1656-1659	and	_	_	_	_
10-38	1660-1662	it	abstract	giv	ana	11-8
10-39	1663-1665	is	_	_	_	_
10-40	1666-1676	classified	_	_	_	_
10-41	1677-1679	as	_	_	_	_
10-42	1680-1687	colonic	_	_	_	_
10-43	1688-1696	delivery	abstract	new	_	_
10-44	1697-1707	biopolymer	_	_	_	_
10-45	1708-1709	.	_	_	_	_

#Text=Although inulin is moderately water soluble , it is used as an encapsulating agent by spray drying due to low viscosity and colorless solutions .
11-1	1710-1718	Although	_	_	_	_
11-2	1719-1725	inulin	person	giv	coref	11-4[86_0]
11-3	1726-1728	is	_	_	_	_
11-4	1729-1739	moderately	person[86]	giv[86]	coref	13-14[0_86]
11-5	1740-1745	water	substance|person[86]	new|giv[86]	_	_
11-6	1746-1753	soluble	person[86]	giv[86]	_	_
11-7	1754-1755	,	_	_	_	_
11-8	1756-1758	it	abstract	giv	_	_
11-9	1759-1761	is	_	_	_	_
11-10	1762-1766	used	_	_	_	_
11-11	1767-1769	as	_	_	_	_
11-12	1770-1772	an	_	_	_	_
11-13	1773-1786	encapsulating	_	_	_	_
11-14	1787-1792	agent	_	_	_	_
11-15	1793-1795	by	_	_	_	_
11-16	1796-1801	spray	object	new	_	_
11-17	1802-1808	drying	_	_	_	_
11-18	1809-1812	due	_	_	_	_
11-19	1813-1815	to	_	_	_	_
11-20	1816-1819	low	substance[89]	new[89]	_	_
11-21	1820-1829	viscosity	substance[89]	new[89]	_	_
11-22	1830-1833	and	_	_	_	_
11-23	1834-1843	colorless	substance[90]	new[90]	_	_
11-24	1844-1853	solutions	substance[90]	new[90]	_	_
11-25	1854-1855	.	_	_	_	_

#Text=However , there are few studies focused on the effect of the incorporation of microencapsulated flavonoids on the oxidative stability of lipid systems .
12-1	1856-1863	However	_	_	_	_
12-2	1864-1865	,	_	_	_	_
12-3	1866-1871	there	_	_	_	_
12-4	1872-1875	are	_	_	_	_
12-5	1876-1879	few	event[91]	new[91]	coref	13-2[98_91]
12-6	1880-1887	studies	event[91]	new[91]	_	_
12-7	1888-1895	focused	_	_	_	_
12-8	1896-1898	on	_	_	_	_
12-9	1899-1902	the	abstract[92]	new[92]	_	_
12-10	1903-1909	effect	abstract[92]	new[92]	_	_
12-11	1910-1912	of	abstract[92]	new[92]	_	_
12-12	1913-1916	the	abstract[92]|abstract[93]	new[92]|new[93]	_	_
12-13	1917-1930	incorporation	abstract[92]|abstract[93]	new[92]|new[93]	_	_
12-14	1931-1933	of	abstract[92]|abstract[93]	new[92]|new[93]	_	_
12-15	1934-1951	microencapsulated	abstract[92]|abstract[93]|substance[94]	new[92]|new[93]|giv[94]	coref	13-10[0_94]
12-16	1952-1962	flavonoids	abstract[92]|abstract[93]|substance[94]	new[92]|new[93]|giv[94]	_	_
12-17	1963-1965	on	abstract[92]|abstract[93]|substance[94]	new[92]|new[93]|giv[94]	_	_
12-18	1966-1969	the	abstract[92]|abstract[93]|substance[94]|abstract[95]	new[92]|new[93]|giv[94]|new[95]	coref	18-38[152_95]
12-19	1970-1979	oxidative	abstract[92]|abstract[93]|substance[94]|abstract[95]	new[92]|new[93]|giv[94]|new[95]	_	_
12-20	1980-1989	stability	abstract[92]|abstract[93]|substance[94]|abstract[95]	new[92]|new[93]|giv[94]|new[95]	_	_
12-21	1990-1992	of	abstract[92]|abstract[93]|substance[94]|abstract[95]	new[92]|new[93]|giv[94]|new[95]	_	_
12-22	1993-1998	lipid	abstract[92]|abstract[93]|substance[94]|abstract[95]|organization|object[97]	new[92]|new[93]|giv[94]|new[95]|giv|giv[97]	coref|coref	17-9|18-42[153_97]
12-23	1999-2006	systems	abstract[92]|abstract[93]|substance[94]|abstract[95]|object[97]	new[92]|new[93]|giv[94]|new[95]|giv[97]	_	_
12-24	2007-2008	.	_	_	_	_

#Text=In previous studies undertaken by our research group , flavonoids were microencapsulated with inulin ( lipid-insoluble polymer ) , where channelizing agents ( lipid-soluble polymer ) were incorporated .
13-1	2009-2011	In	_	_	_	_
13-2	2012-2020	previous	event[98]	giv[98]	_	_
13-3	2021-2028	studies	event[98]	giv[98]	_	_
13-4	2029-2039	undertaken	_	_	_	_
13-5	2040-2042	by	_	_	_	_
13-6	2043-2046	our	person|organization[100]	acc|new[100]	_	_
13-7	2047-2055	research	organization[100]	new[100]	_	_
13-8	2056-2061	group	organization[100]	new[100]	_	_
13-9	2062-2063	,	_	_	_	_
13-10	2064-2074	flavonoids	substance	giv	coref	14-7[107_0]
13-11	2075-2079	were	_	_	_	_
13-12	2080-2097	microencapsulated	_	_	_	_
13-13	2098-2102	with	_	_	_	_
13-14	2103-2109	inulin	substance	giv	appos	13-16[103_0]
13-15	2110-2111	(	_	_	_	_
13-16	2112-2127	lipid-insoluble	substance[103]	giv[103]	appos	13-24[105_103]
13-17	2128-2135	polymer	substance[103]	giv[103]	_	_
13-18	2136-2137	)	_	_	_	_
13-19	2138-2139	,	_	_	_	_
13-20	2140-2145	where	_	_	_	_
13-21	2146-2158	channelizing	_	_	_	_
13-22	2159-2165	agents	person	new	_	_
13-23	2166-2167	(	_	_	_	_
13-24	2168-2181	lipid-soluble	substance[105]	giv[105]	coref	16-7[0_105]
13-25	2182-2189	polymer	substance[105]	giv[105]	_	_
13-26	2190-2191	)	_	_	_	_
13-27	2192-2196	were	_	_	_	_
13-28	2197-2209	incorporated	_	_	_	_
13-29	2210-2211	.	_	_	_	_

#Text=These microparticles were able to release the encapsulated flavonoids and improve the oxidative stability of methyl linoleate and vegetable oils , which was attributed to the formation of channels inside the microparticles , favoring the diffusion of flavonoids .
14-1	2212-2217	These	object[106]	new[106]	coref	14-31[113_106]
14-2	2218-2232	microparticles	object[106]	new[106]	_	_
14-3	2233-2237	were	_	_	_	_
14-4	2238-2242	able	_	_	_	_
14-5	2243-2245	to	_	_	_	_
14-6	2246-2253	release	_	_	_	_
14-7	2254-2257	the	substance[107]	giv[107]	coref	14-38[0_107]
14-8	2258-2270	encapsulated	substance[107]	giv[107]	_	_
14-9	2271-2281	flavonoids	substance[107]	giv[107]	_	_
14-10	2282-2285	and	_	_	_	_
14-11	2286-2293	improve	_	_	_	_
14-12	2294-2297	the	abstract[108]	new[108]	_	_
14-13	2298-2307	oxidative	abstract[108]	new[108]	_	_
14-14	2308-2317	stability	abstract[108]	new[108]	_	_
14-15	2318-2320	of	abstract[108]	new[108]	_	_
14-16	2321-2327	methyl	abstract[108]|substance[109]	new[108]|new[109]	_	_
14-17	2328-2337	linoleate	abstract[108]|substance[109]	new[108]|new[109]	_	_
14-18	2338-2341	and	abstract[108]	new[108]	_	_
14-19	2342-2351	vegetable	abstract[108]|substance[110]	new[108]|new[110]	_	_
14-20	2352-2356	oils	abstract[108]|substance[110]	new[108]|new[110]	_	_
14-21	2357-2358	,	_	_	_	_
14-22	2359-2364	which	_	_	_	_
14-23	2365-2368	was	_	_	_	_
14-24	2369-2379	attributed	_	_	_	_
14-25	2380-2382	to	_	_	_	_
14-26	2383-2386	the	abstract[111]	new[111]	_	_
14-27	2387-2396	formation	abstract[111]	new[111]	_	_
14-28	2397-2399	of	abstract[111]	new[111]	_	_
14-29	2400-2408	channels	abstract[111]|object[112]	new[111]|new[112]	_	_
14-30	2409-2415	inside	abstract[111]|object[112]	new[111]|new[112]	_	_
14-31	2416-2419	the	abstract[111]|object[112]|object[113]	new[111]|new[112]|giv[113]	coref	16-35[131_113]
14-32	2420-2434	microparticles	abstract[111]|object[112]|object[113]	new[111]|new[112]|giv[113]	_	_
14-33	2435-2436	,	_	_	_	_
14-34	2437-2445	favoring	_	_	_	_
14-35	2446-2449	the	abstract[114]	new[114]	_	_
14-36	2450-2459	diffusion	abstract[114]	new[114]	_	_
14-37	2460-2462	of	abstract[114]	new[114]	_	_
14-38	2463-2473	flavonoids	abstract[114]|substance	new[114]|giv	coref	18-9
14-39	2474-2475	.	_	_	_	_

#Text=In general , powders obtained by spray-drying are amorphous .
15-1	2476-2478	In	_	_	_	_
15-2	2479-2486	general	person	new	_	_
15-3	2487-2488	,	_	_	_	_
15-4	2489-2496	powders	object	new	_	_
15-5	2497-2505	obtained	_	_	_	_
15-6	2506-2508	by	_	_	_	_
15-7	2509-2521	spray-drying	abstract	giv	coref	16-12[123_0]
15-8	2522-2525	are	_	_	_	_
15-9	2526-2535	amorphous	_	_	_	_
15-10	2536-2537	.	_	_	_	_

#Text=However , in the case of inulin , process variables of spray-drying such as feed temperature and inlet air temperature have been reported to influence both the morphology and the degree of crystallinity of the microparticles .
16-1	2538-2545	However	_	_	_	_
16-2	2546-2547	,	_	_	_	_
16-3	2548-2550	in	_	_	_	_
16-4	2551-2554	the	substance[119]	new[119]	_	_
16-5	2555-2559	case	substance[119]	new[119]	_	_
16-6	2560-2562	of	substance[119]	new[119]	_	_
16-7	2563-2569	inulin	substance[119]|substance	new[119]|giv	coref	18-17
16-8	2570-2571	,	_	_	_	_
16-9	2572-2579	process	abstract|abstract[122]	new|new[122]	_	_
16-10	2580-2589	variables	abstract[122]	new[122]	_	_
16-11	2590-2592	of	_	_	_	_
16-12	2593-2605	spray-drying	substance[123]	giv[123]	_	_
16-13	2606-2610	such	substance[123]	giv[123]	_	_
16-14	2611-2613	as	substance[123]	giv[123]	_	_
16-15	2614-2618	feed	substance[123]|substance|abstract[125]	giv[123]|new|new[125]	_	_
16-16	2619-2630	temperature	substance[123]|abstract[125]	giv[123]|new[125]	_	_
16-17	2631-2634	and	substance[123]	giv[123]	_	_
16-18	2635-2640	inlet	substance[123]|abstract[127]	giv[123]|new[127]	_	_
16-19	2641-2644	air	substance[123]|abstract|abstract[127]	giv[123]|new|new[127]	_	_
16-20	2645-2656	temperature	substance[123]|abstract[127]	giv[123]|new[127]	_	_
16-21	2657-2661	have	_	_	_	_
16-22	2662-2666	been	_	_	_	_
16-23	2667-2675	reported	_	_	_	_
16-24	2676-2678	to	_	_	_	_
16-25	2679-2688	influence	abstract	new	none|none	16-25[0_148]|17-22
16-26	2689-2693	both	person[128]	new[128]	_	_
16-27	2694-2697	the	person[128]	new[128]	_	_
16-28	2698-2708	morphology	person[128]	new[128]	_	_
16-29	2709-2712	and	_	_	_	_
16-30	2713-2716	the	abstract[129]	new[129]	_	_
16-31	2717-2723	degree	abstract[129]	new[129]	_	_
16-32	2724-2726	of	abstract[129]	new[129]	_	_
16-33	2727-2740	crystallinity	abstract[129]|substance[130]	new[129]|new[130]	_	_
16-34	2741-2743	of	abstract[129]|substance[130]	new[129]|new[130]	_	_
16-35	2744-2747	the	abstract[129]|substance[130]|object[131]	new[129]|new[130]|giv[131]	coref	17-2[132_131]
16-36	2748-2762	microparticles	abstract[129]|substance[130]|object[131]	new[129]|new[130]|giv[131]	_	_
16-37	2763-2764	.	_	_	_	_

#Text=When the flavonoid-inulin microparticles are incorporated into a lipid system , the physical state of these microparticles ( semi-crystalline/amorphous ) may influence the oxidative stability of the system , but this still has not been addressed .
17-1	2765-2769	When	_	_	_	_
17-2	2770-2773	the	object[132]	giv[132]	coref	17-16[136_132]
17-3	2774-2790	flavonoid-inulin	object[132]	giv[132]	_	_
17-4	2791-2805	microparticles	object[132]	giv[132]	_	_
17-5	2806-2809	are	_	_	_	_
17-6	2810-2822	incorporated	_	_	_	_
17-7	2823-2827	into	_	_	_	_
17-8	2828-2829	a	abstract[134]	new[134]	coref	17-27[139_134]
17-9	2830-2835	lipid	organization|abstract[134]	giv|new[134]	_	_
17-10	2836-2842	system	abstract[134]	new[134]	_	_
17-11	2843-2844	,	_	_	_	_
17-12	2845-2848	the	abstract[135]	new[135]	_	_
17-13	2849-2857	physical	abstract[135]	new[135]	_	_
17-14	2858-2863	state	abstract[135]	new[135]	_	_
17-15	2864-2866	of	abstract[135]	new[135]	_	_
17-16	2867-2872	these	abstract[135]|object[136]	new[135]|giv[136]	coref	18-15[145_136]
17-17	2873-2887	microparticles	abstract[135]|object[136]	new[135]|giv[136]	_	_
17-18	2888-2889	(	_	_	_	_
17-19	2890-2916	semi-crystalline/amorphous	person	new	_	_
17-20	2917-2918	)	_	_	_	_
17-21	2919-2922	may	_	_	_	_
17-22	2923-2932	influence	abstract	new	coref	18-24[148_0]
17-23	2933-2936	the	abstract[138]	new[138]	_	_
17-24	2937-2946	oxidative	abstract[138]	new[138]	_	_
17-25	2947-2956	stability	abstract[138]	new[138]	_	_
17-26	2957-2959	of	abstract[138]	new[138]	_	_
17-27	2960-2963	the	abstract[138]|abstract[139]	new[138]|giv[139]	ana	17-31[0_139]
17-28	2964-2970	system	abstract[138]|abstract[139]	new[138]|giv[139]	_	_
17-29	2971-2972	,	_	_	_	_
17-30	2973-2976	but	_	_	_	_
17-31	2977-2981	this	abstract	giv	_	_
17-32	2982-2987	still	_	_	_	_
17-33	2988-2991	has	_	_	_	_
17-34	2992-2995	not	_	_	_	_
17-35	2996-3000	been	_	_	_	_
17-36	3001-3010	addressed	_	_	_	_
17-37	3011-3012	.	_	_	_	_

#Text=The objective of this research was to design flavonoids ( epicatechin and quercetin ) microparticles with inulin as encapsulating agent and to evaluate the influence of the physical state of spray-dried flavonoid microparticles ( semi-crystalline/amorphous ) on the oxidative stability of lipid systems .
18-1	3013-3016	The	abstract[141]	new[141]	_	_
18-2	3017-3026	objective	abstract[141]	new[141]	_	_
18-3	3027-3029	of	abstract[141]	new[141]	_	_
18-4	3030-3034	this	abstract[141]|abstract[142]	new[141]|new[142]	_	_
18-5	3035-3043	research	abstract[141]|abstract[142]	new[141]|new[142]	_	_
18-6	3044-3047	was	_	_	_	_
18-7	3048-3050	to	_	_	_	_
18-8	3051-3057	design	_	_	_	_
18-9	3058-3068	flavonoids	substance	giv	appos	18-11[144_0]
18-10	3069-3070	(	_	_	_	_
18-11	3071-3082	epicatechin	substance[144]	giv[144]	_	_
18-12	3083-3086	and	substance[144]	giv[144]	_	_
18-13	3087-3096	quercetin	substance[144]	giv[144]	_	_
18-14	3097-3098	)	_	_	_	_
18-15	3099-3113	microparticles	object[145]	giv[145]	coref	18-31[151_145]
18-16	3114-3118	with	object[145]	giv[145]	_	_
18-17	3119-3125	inulin	object[145]|substance	giv[145]|giv	_	_
18-18	3126-3128	as	_	_	_	_
18-19	3129-3142	encapsulating	_	_	_	_
18-20	3143-3148	agent	person	new	_	_
18-21	3149-3152	and	_	_	_	_
18-22	3153-3155	to	_	_	_	_
18-23	3156-3164	evaluate	_	_	_	_
18-24	3165-3168	the	abstract[148]	new[148]	_	_
18-25	3169-3178	influence	abstract[148]	new[148]	_	_
18-26	3179-3181	of	abstract[148]	new[148]	_	_
18-27	3182-3185	the	abstract[148]|abstract[149]	new[148]|new[149]	_	_
18-28	3186-3194	physical	abstract[148]|abstract[149]	new[148]|new[149]	_	_
18-29	3195-3200	state	abstract[148]|abstract[149]	new[148]|new[149]	_	_
18-30	3201-3203	of	abstract[148]|abstract[149]	new[148]|new[149]	_	_
18-31	3204-3215	spray-dried	abstract[148]|abstract[149]|object[151]	new[148]|new[149]|giv[151]	_	_
18-32	3216-3225	flavonoid	abstract[148]|abstract[149]|object|object[151]	new[148]|new[149]|new|giv[151]	_	_
18-33	3226-3240	microparticles	abstract[148]|abstract[149]|object[151]	new[148]|new[149]|giv[151]	_	_
18-34	3241-3242	(	_	_	_	_
18-35	3243-3269	semi-crystalline/amorphous	_	_	_	_
18-36	3270-3271	)	_	_	_	_
18-37	3272-3274	on	_	_	_	_
18-38	3275-3278	the	abstract[152]	giv[152]	_	_
18-39	3279-3288	oxidative	abstract[152]	giv[152]	_	_
18-40	3289-3298	stability	abstract[152]	giv[152]	_	_
18-41	3299-3301	of	abstract[152]	giv[152]	_	_
18-42	3302-3307	lipid	abstract[152]|object[153]	giv[152]|giv[153]	_	_
18-43	3308-3315	systems	abstract[152]|object[153]	giv[152]|giv[153]	_	_
18-44	3316-3317	.	_	_	_	_
